Bilateral rhegmatogenous retinal detachments in a patient taking pazopanib: A case report

PURPOSE: To report a case of bilateral rhegmatogenous retinal detachments (RRD) associated with treatment with the systemic tyrosine kinase inhibitor pazopanib. OBSERVATIONS: A 57-year-old man with history of renal cell carcinoma was treated with pazopanib therapy for four months. He presented to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Nolan J., De Alba, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924531/
https://www.ncbi.nlm.nih.gov/pubmed/35308590
http://dx.doi.org/10.1016/j.ajoc.2022.101463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924531/
https://www.ncbi.nlm.nih.gov/pubmed/35308590
http://dx.doi.org/10.1016/j.ajoc.2022.101463

Ejemplares similares